Skip to main content

Heidi launches first AI device for clinical work: Remote

Heidi AI
Log inGet Heidi free
Acute Medicine Specialist Template

Mounjaro consultation

A professional Acute Medicine Specialist template for healthcare professionals.
Use this templateBrowse more templates
Browse more templates

About this template

Need a clear and concise way to document Mounjaro consultations? This template is designed for acute medicine specialists and other clinicians prescribing GLP-1 receptor agonists. It covers essential aspects like weight, BMI, co-morbidities, drug history, and contraindications. The template also includes sections on the mechanism of action, risks, and side effects of GLP-1 agonists, ensuring comprehensive documentation. With Heidi, this template can be quickly populated from your patient's visit, saving you time and improving the accuracy of your clinical notes. Streamline your documentation process and ensure all necessary information is captured efficiently.

Preview template

Weight height BMI Weight: 110kg, Height: 1.75m, BMI: 35.9 Qualifies for treatment on BMI (yes/no): yes Other weight related co morbidities: Hypertension, Hyperlipidaemia Relevant past medical history: Type 2 Diabetes Mellitus, diagnosed 2018; Hypertension, diagnosed 2020; Hyperlipidaemia, diagnosed 2021. Drug history: Metformin 1000mg twice daily, Lisinopril 20mg daily, Atorvastatin 40mg daily. Absolute contraindications: History of medullary thyroid carcinoma. Mechanism of action of GLP-1 agonists: GLP-1 agonists mimic the action of the naturally occurring incretin hormone GLP-1. They stimulate insulin secretion, suppress glucagon secretion, slow gastric emptying, and promote satiety. Appetite suppressant receptor locations actions on the body: GLP-1 receptors are located in the brain, particularly in areas involved in appetite regulation. Activation of these receptors leads to reduced appetite and increased feelings of fullness. Risks and side effects of GLP-1 agonists: Common side effects include nausea, vomiting, diarrhoea, and constipation. Less common side effects include pancreatitis and gallbladder problems. Safely taking GLP-1 agonists: Patients should be educated on proper injection technique, potential side effects, and the importance of monitoring blood glucose levels. They should also be advised to report any severe or persistent side effects to their healthcare provider. Review structure and plan: Discussed the benefits and risks of Mounjaro. Patient understands the treatment plan and is willing to proceed. Prescribed Mounjaro 2.5mg weekly, to be increased to 5mg after 4 weeks if tolerated. Follow-up appointment scheduled in 4 weeks to assess efficacy and tolerability. Date: 1 November 2024.
Weight height BMI [qualifies for treatment on BMI (yes/no) (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely.)] [other weight related co morbidities (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely.)] [relevant past medical history (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely.)] [drug history (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely.)] [absolute contraindications (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely.)] Mechanism of action of GLP-1 agonists [appetite suppressant receptor locations actions on the body (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely.)] Risks and side effects of GLP-1 agonists [side effects (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely.)] [safely taking GLP-1 agonists (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely.)] [review structure and plan (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely.)] (For each section, only include if explicitly mentioned in transcript or context, else omit section entirely. Never come up with your own patient details, assessment, plan, interventions, evaluation, or next steps—use only the transcript, contextual notes, or clinical note as reference for all information. If any information related to a placeholder has not been explicitly mentioned, do not state that in the output; simply leave the relevant placeholder or section out entirely. Use as many lines, paragraphs, or bullet points as needed to capture all relevant information from the transcript.)
Browse more templatesUse this template

How to use this template

Step 1: Download the template
1Step 1

Download the template

Get started by downloading the template to your device

Step 2: Customize to your needs
2Step 2

Customize to your needs

Tailor the template to match your specific requirements

Step 3: Deploy and share
3Step 3

Deploy and share

Implement your customized template and share with your team

Browse more templatesUse this template

Related Templates

Note

EC Initial Assessment

Heidi Team

Acute Medicine Specialist, South Africa

Note

Emergency Centre Assessment

Heidi Team

Acute Medicine Specialist, South Africa

Start practicing with a partner

Care is better with Heidi
Use this template

Specialty

Acute Medicine Specialist

Used

48 times

Type

Note

Last edited

9/25/2025

Created by

Lauren Airey

Ask AI about Heidi:

Heidi AI

Heidi. By your side.

© 2026 Heidi. All rights reserved.

Specialties

  • Family Medicine

  • Specialists

  • Nurses

  • Mental Health

  • Allied Health

  • Dentists

  • Veterinarians

  • Trainees

Compliance

  • Safety

  • Trust Center

  • AU/NZ

  • Canada

  • UK

  • GDPR

  • HIPAA

Product

  • Pricing

  • Changelog

  • Downloads

  • Heidi Guides

  • Help Centre

  • System Status

  • System Requirements

About Us

  • Contact Us

  • Company

  • Customer Stories

  • Media

  • Open Roles

    10+
  • People

  • Partnerships

Resources

  • Blog

  • ROI Calculator

  • Resource Centre

  • Template Community

  • FAQs

Legal

  • Privacy Policy

  • Terms of Service

  • Usage Policy

  • UKGDPR Policy

  • Accessibility